R&D News | pharmaphorum

News

scientifically visualization of a coronavirus spike protein

Atriva takes MEK inhibitor into phase 2 for COVID-19

Atriva Therapeutics is starting a phase 2 trial of its MEK inhibitor ATR-002 in patients with coronavirus infections, saying the drug could help prevent patients progressing to

News

AstraZeneca's (AZ) Tagrisso (osimertinib)

Given after surgery, AZ’s Tagrisso prevents lung cancer comi...

AstraZeneca opened its account at this year’ virtual ASCO meeting with data showing that adjuvant (post-surgery) use of Tagrisso delays the recurrence of EGFR-positive non-smal

News

PureTech to develop drug to treat lung scarring in COVID-19 ...

US biotech PureTech is to develop its most advanced pipeline drug LYT-100 as a potential treatment for inflammation and lung scarring in patients who have serious cases of COVID-19 or who h

News

Closeup of X-ray photography of human brain

Novartis builds case for MS drug ofatumumab as FDA decision ...

Novartis has reported new data with its multiple sclerosis (MS) drug ofatumumab showing that it can suppress disease activity for up to two years, as it waits for an FDA decisi

News

AI and cancer care: Three ways artificial intelligence may transform cancer outcomes

AI drug discovery firm Exscientia gets $60M cash injection

UK artificial intelligence specialist Exscientia has topped up its coffers with a $60 million Series C funding round that will be used to advance projects into clinical trials.

News

Merck & Co and IAVI join forces to develop COVID-19 vaccine

Merck & Co has joined with the non-profit scientific research organisation, the International AIDS Vaccine Initiative (IAVI), to develop a potential vaccine against the SARS-CoV-2 coron

Atriva takes MEK inhibitor into phase 2 for COVID-19

Given after surgery, AZ’s Tagrisso prevents lung cancer comi...

PureTech to develop drug to treat lung scarring in COVID-19 ...

Novartis builds case for MS drug ofatumumab as FDA decision ...

AI drug discovery firm Exscientia gets $60M cash injection

Merck & Co and IAVI join forces to develop COVID-19 vaccine

Third Rock in $2bn drug-hunting pact with China's Funnel

Securing your ROI: Turning post-acquisition integration into...

News

Editor's Picks